Skip to main content
EXICURE, INC. logo

EXICURE, INC. — Investor Relations & Filings

Ticker · XCUR ISIN · US30205M1018 LEI · 549300IMD6I0V06I2Z87 US Professional, scientific and technical activities
Filings indexed 519 across all filing types
Latest filing 2020-08-12 Interim / Quarterly Rep…
Country US United States of America
Listing US XCUR

About EXICURE, INC.

https://www.exicuretx.com/

Exicure, Inc. is an early-stage biotechnology company that has historically focused on developing nucleic acid therapies based on its proprietary Spherical Nucleic Acid (SNA) technology. The company's platform is designed to create therapeutics that target ribonucleic acid (RNA) to address validated targets. Past development efforts have concentrated on neurological disorders and other conditions, leveraging the SNA architecture for gene silencing and immunomodulatory applications.

Recent filings

Filing Released Lang Actions
10-Q
Interim / Quarterly Report Q2 2020
2020-08-12 English
8-K
Regulatory Filings
2020-08-12 English
FORM 4 SUBMISSION
Director's Dealing
2020-07-08 English
FORM 4
Director's Dealing
2020-06-17 English
FORM 4 SUBMISSION
Director's Dealing
2020-06-17 English
8-K
Regulatory Filings
2020-06-16 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.